Deutsche Bank Ag\ Marker Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$1.88 - $3.56 $37,547 - $71,100	-19,972 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$1.47 - $3.29 $2,716 - $6,079	-1,848 Reduced 8.47%	19,972 $44,000
Q4 2020 Feb 16, 2021	BUY	$1.36 - $1.75 $3,740 - $4,812	2,750 Added 14.42%	21,820 $31,000
Q3 2020 Nov 12, 2020	BUY	$1.5 - $2.2 $3,936 - $5,772	2,624 Added 15.96%	19,070 $29,000
Q2 2020 Aug 13, 2020	SELL	$1.69 - $2.79 $21,060 - $34,768	-12,462 Reduced 43.11%	16,446 $34,000
Q1 2020 May 14, 2020	SELL	$1.59 - $3.35 $15,154 - $31,928	-9,531 Reduced 24.8%	28,908 $55,000
Q4 2019 Feb 14, 2020	BUY	$2.68 - $4.85 $81,608 - $147,687	30,451 Added 381.21%	38,439 $109,000
Q3 2019 Nov 14, 2019	SELL	$4.1 - $9.0 $56,087 - $123,120	-13,680 Reduced 63.13%	7,988 $39,000
Q2 2019 Aug 14, 2019	BUY	$5.15 - $7.92 $111,590 - $171,610	21,668 New	21,668 $170,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $288M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.